Morgan Stanley has made strategic upgrades to key companies including Johnson & Johnson and Nokia Corp, significantly increasing their price targets. Johnson & Johnson was raised to 'Overweight' with a target of $262, while Nokia’s target increased to €6.50. Additionally, Lumentum's price target was lifted to $350, reflecting Morgan Stanley's bullish sentiment on these stocks amid favorable market catalysts. The firm also reiterated its positive outlook on Boston Scientific Corporation following a notable deal.
“Morgan Stanley · upgraded · Johnson & Johnson · to Overweight from Equal-Weight”
“Morgan Stanley · increased · its price target on Lumentum · to $350 from $304”
“Morgan Stanley · upgraded · Johnson & Johnson · to Overweight from Equal-Weight”
“Morgan Stanley · upgraded · Nokia Corp (NYSE:NOK) · to Overweight from Equal Weight”
“Morgan Stanley · changed the price target · Nokia Corp (NYSE:NOK) · to €6.50 from €4.20”
“Morgan Stanley · reiterated its · positive view on Boston Scientific Corporation · following the Penumbra deal”
“Morgan Stanley · sees some · clear catalysts · that make the stock valuation appear highly attractive at this point”
“Lumentum Holdings Inc. · received a price target from Morgan Stanley of · price target · $350”
“Morgan Stanley · provided an upgrade from the previous price target of · price target · $304”
“Morgan Stanley · maintained an rating for its stock of · rating · equal weight”
“Morgan Stanley · noted that LITE was · highest volume for incremental investors · as we closed out the year”
“Morgan Stanley · reported that investors are turning more neutral ahead of upcoming results due to concerns about · higher expectations · how much higher”
.svg&width=160)